Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125273471 | 12527347 | 1 | I | 20160622 | 20160705 | 20160705 | PER | US-BAYER-2016-124067 | BAYER | 79.00 | YR | E | M | Y | 76.64000 | KG | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125273471 | 12527347 | 1 | PS | CLARITIN REDITABS | LORATADINE | 1 | Oral | 1 DF, QD | JEBT78 | 20704 | 1 | DF | ORODISPERSIBLE TABLET | QD | |||||
| 125273471 | 12527347 | 2 | SS | CLARITIN | LORATADINE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 125273471 | 12527347 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 125273471 | 12527347 | 4 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 125273471 | 12527347 | 5 | C | OPTI SAFE AREDS | 2 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125273471 | 12527347 | Expired product administered | |
| 125273471 | 12527347 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |